Core Laboratories director Kwaku Temeng resigns Oct 1 over strategy, governance disagreement

Core Laboratories Inc. /DE/

Kwaku Temeng resigns as director effective Oct 1, 2026; cites disagreement over strategic direction and governance.
He served as Chairman of Nominating Committee and member of Compensation Committee.
Board says primary disagreement concerns succession planning approach; Temeng also has research-priority concerns.
Resignation letter filed as Exhibit 17.1; no replacement director announced.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Kwaku Temeng

director

CLB · Core Laboratories Inc. /DE/

Effective: 2026-10-01
Filed: August 25, 2026, 4:51 PM ET

On August 19, 2026, Kwaku Temeng verbally notified the Board of Directors of Core Laboratories Inc. (the “Company”) of his intention to resign as a director of the Company effective October 1, 2026.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Kwaku Temeng resigned as director at Core Laboratories Inc. /DE/.

Action: resigned
Role: director

Exact text from the filing

On August 19, 2026, Kwaku Temeng verbally notified the Board of Directors of Core Laboratories Inc. (the “Company”) of his intention to resign as a director of the Company effective October 1, 2026.

View on SEC.gov

Core Laboratories Inc. /DE/ filing history →

Source: SEC EDGAR

accession 0001193125-26-365271

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.